Literature DB >> 33641067

The important roles of microRNAs in depression: new research progress and future prospects.

Chenggui Miao1,2,3,4, Jun Chang5.   

Abstract

MicroRNAs (miRNAs) are non-encoding, single-stranded RNA molecules of about 22 nucleotides in length encoded by endogenous genes involved in posttranscriptional gene expression regulation. Studies have shown that miRNAs participate in a series of important pathophysiological processes, including the pathogenesis of depression. This article systematically summarized the research results published in the field of miRNAs and depression, which mainly involved three topics: circulating miRNAs as markers for diagnosis and prognosis of depression, the regulatory roles of miRNAs in the pathogenesis of depression, and the roles of miRNAs in the mechanisms of depression treatment. By summarizing and analyzing the research literature in recent years, we found that some circulating miRNAs can be potential biomarkers for the diagnosis and prognostic evaluation of depression. miRNAs that disorderly expressed during the disease play important roles in the depression pathogenesis, and miRNAs also play roles in the mechanisms of psychotherapy and drug therapy for depression. Elucidating the important roles of miRNAs in depression will bring people's understanding of the pathogenesis of depression to a new level. In addition, these miRNAs may be developed as new biomarkers for diagnosing depression, or as drug targets, or these molecules may be used as new drugs, which may provide new means for the treatment of depression. KEY MESSAGES: • The research results of miRNAs and depression are reviewed. • Circulating miRNAs can be potential biomarkers for depression. • MiRNAs play important roles in the depression pathogenesis. • MiRNAs play important roles in drug therapy for depression.

Entities:  

Keywords:  Depression; Hippocampal neuron dysfunction; MicroRNA; Prefrontal cortex disorder; Psychotherapy

Mesh:

Substances:

Year:  2021        PMID: 33641067     DOI: 10.1007/s00109-021-02052-8

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  122 in total

1.  Co-Variation of Peripheral Levels of miR-1202 and Brain Activity and Connectivity During Antidepressant Treatment.

Authors:  Juan Pablo Lopez; Fabricio Pereira; Stéphane Richard-Devantoy; Marcelo Berlim; Eduardo Chachamovich; Laura M Fiori; Paola Niola; Gustavo Turecki; Fabrice Jollant
Journal:  Neuropsychopharmacology       Date:  2017-01-12       Impact factor: 7.853

2.  microRNA-124: a putative therapeutic target and biomarker for major depression.

Authors:  Yogesh Dwivedi
Journal:  Expert Opin Ther Targets       Date:  2017-05-25       Impact factor: 6.902

Review 3.  Does Pharmacogenomic Testing Improve Clinical Outcomes for Major Depressive Disorder? A Systematic Review of Clinical Trials and Cost-Effectiveness Studies.

Authors:  Joshua D Rosenblat; Yena Lee; Roger S McIntyre
Journal:  J Clin Psychiatry       Date:  2017-06       Impact factor: 4.384

Review 4.  A review of dietary and microbial connections to depression, anxiety, and stress.

Authors:  Andrew M Taylor; Hannah D Holscher
Journal:  Nutr Neurosci       Date:  2018-07-09       Impact factor: 4.994

Review 5.  Depression during perimenopause: the role of the obstetrician-gynecologist.

Authors:  Greta B Raglan; Jay Schulkin; Elizabeth Micks
Journal:  Arch Womens Ment Health       Date:  2019-02-13       Impact factor: 3.633

Review 6.  Targeting RNA in mammalian systems with small molecules.

Authors:  Anita Donlic; Amanda E Hargrove
Journal:  Wiley Interdiscip Rev RNA       Date:  2018-05-03       Impact factor: 9.957

Review 7.  Cognitive dysfunction in major depressive disorder.

Authors:  Matthew J Knight; Bernhard T Baune
Journal:  Curr Opin Psychiatry       Date:  2018-01       Impact factor: 4.741

Review 8.  Genetics of resilience: Implications from genome-wide association studies and candidate genes of the stress response system in posttraumatic stress disorder and depression.

Authors:  Stephan Maul; Ina Giegling; Chiara Fabbri; Filippo Corponi; Alessandro Serretti; Dan Rujescu
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2019-10-04       Impact factor: 3.568

Review 9.  The potential function of microRNAs as biomarkers and therapeutic targets in multiple myeloma.

Authors:  Bingying Zhu; Shaoqing Ju; Haidan Chu; Xianjuan Shen; Yan Zhang; Xi Luo; Hui Cong
Journal:  Oncol Lett       Date:  2018-03-02       Impact factor: 2.967

Review 10.  MicroRNAs associated with therapy of non-small cell lung cancer.

Authors:  Junmi Lu; Yuting Zhan; Juan Feng; Jiadi Luo; Songqing Fan
Journal:  Int J Biol Sci       Date:  2018-03-10       Impact factor: 6.580

View more
  1 in total

1.  Circulating microRNA associated with future relapse status in major depressive disorder.

Authors:  Qingqin S Li; David Galbraith; Randall L Morrison; Madhukar H Trivedi; Wayne C Drevets
Journal:  Front Psychiatry       Date:  2022-08-17       Impact factor: 5.435

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.